A Chronic-Dose Safety and Efficacy Study of Albuterol Multi-Dose Dry Powder Inhaler in Pediatric Asthmatics
Clinical trial NCT02126839 · COMPLETED
Trial details
- NCT number
- NCT02126839
- Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-05-01
- Primary completion
- 2015-02-01
- Enrollment
- 186
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.